Related Experiment Video

Updated: Dec 30, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.1K

TGF-β1 suppresses syndecan-2 expression through the ERK signaling pathway in nucleus pulposus cells

Weifeng Yan1, Xiaolin Wang2, Yuxin Pei3

  • 1Department of Orthopaedics, The Hospital of Zhejiang General Corps of Armed Police Forces Jiaxing, China.

International Journal of Clinical and Experimental Pathology
|January 16, 2020
PubMed

Insights

Syndecan-2 (SDC2) expression correlates with intervertebral disc degeneration (IVDD). Inhibiting SDC2 in disc cells reduces key enzymes, suggesting SDC2 as a potential therapeutic target for controlling IVDD.

Area of Science:

  • Biomedical research
  • Orthopedics
  • Cell biology

Background:

  • Intervertebral disc degeneration (IVDD) is a primary cause of low back pain, leading to significant economic burdens.
  • Understanding IVDD mechanisms is crucial for developing effective treatments.
  • The syndecan (SDC) family is implicated in various physiological and pathological processes.

Purpose of the Study:

  • To investigate the role of SDC2 in IVDD.
  • To explore the regulatory mechanism of SDC2 expression in nucleus pulposus cells.
  • To assess the therapeutic potential of targeting SDC2 for IVDD.

Main Methods:

  • Correlation analysis of SDC2 expression with IVDD grades in human samples.
  • In vitro studies using nucleus pulposus cells to examine TGF-β1 and ERK1/2 signaling.
  • Gene knockdown experiments to assess the impact of SDC2 on aggrecanase expression.

Main Results:

  • SDC2 expression levels were positively correlated with the severity of IVDD in human tissues.
  • Transforming growth factor-β1 (TGF-β1) was found to inhibit SDC2 expression via ERK1/2 pathway activation in nucleus pulposus cells.
  • Knockdown of SDC2 significantly reduced the expression of aggrecanase-1 and aggrecanase-2.

Conclusions:

  • SDC2 plays a significant role in the pathogenesis of IVDD.
  • Targeting SDC2 may offer a novel therapeutic strategy for managing IVDD by controlling extracellular matrix degradation.
Keywords:
ERK signalingSyndecan-2degenerationintervertebral disctransforming growth factor-β1

More Related Videos

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

11.6K
Induction and Analysis of Epithelial to Mesenchymal Transition10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

36.4K

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.3K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.5K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K